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Abstract- A member of homeodomain protein namely TGIF2LX has been implicated as a tumor suppressor 
gene in human malignancy as well as in spermatogenesis. However, to our knowledge, dynamic functional 
evidence of the TGIF2LX has not yet been provided. The aim of the present study was to investigate the 
human TGIF2LX target gene(s) using a cDNA-AFLP as a differential display method. A pEGFP-TGIF2LX 
construct containing the wild-type TGIF2LX cDNA was stably transfected into SW48 cells. UV microscopic 
analysis and Real-time RT-PCR were used to confirm TGIF2LX expression. The mRNA expressions of 
TGIF2LX in transfected SW48 cells, the cells containing empty vector (pEGFP-N), and untransfected cells 
were compared. Also, a Real-time PCR technique was applied to validate cDNA-AFLP results. The results 
revealed a significant down-regulation and up-regulationby TGIF2LX of Nir1 and Nir2 genes, respectively. 
The genes are engaged in the cell morphogenesis process. Our findings may provide new insight into the 
complex molecular pathways underlying colorectal cancer development. 
© 2016 Tehran University of Medical Sciences. All rights reserved.  
Acta Med Iran, 2016;54(5):302-307. 
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Introduction 
 
Homeodomain transcription factors play 
fundamental roles in cellular proliferation, 
differentiation as well as cell fate (1). The homeobox 
genes are a diverse group of genes characterized by a 
conserved 180 base-pair motif encoding a homeodomain 
with three structurally conserved helices (2). These 
genes have a particular DNA sequence, the homeobox, 
which encodes a very variable protein domain named 
homeodomain. Many homeodomain proteins are 
transcription factors with important roles in embryonic 
development and cell differentiation, several of which 
are involved in human disease and congenital 
abnormalities (3,4). 
One subfamily of homeobox genes encodes proteins 
with atypical homeodomain referred to as three amino 
acid loop extension (TALE) which are described by the 
presence of three extra amino acids between helix 1 and 
helix 2(3,5). The third helix has amajor role in DNA-
binding site recognition (5). TALE homeodomain 
proteins are crucial transcription factors for embryonic 
progress and early development (6,7). Four TALE 
classes have been identified in animals: PBC, MEIS, 
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TGIF and IRO (Iroquois) (8). 
TGIF (referred to as transforming growth factor-β-
induced factor 5’-TG-3’ interacting factor) genes encode 
TALE-class homeodomain proteins including TGIF1, 
TGIF2, TGIF2LX (transforming growth factor-β-
induced factor 2-like, X-linked) andTGIF2LY 
(transforming growth factor-β-induced factor 2-like, Y-
linked), that act as multifunctional repressors of TGF-
βsignaling. These transcription factors function in 
normal and abnormal developments (3,9-11). 
TGIF2 is frequently expressed in human tissues, 
with especially high expression in the heart, kidney, 
and testis (1). 
The human TGIF2LX gene is located on X-
chromosome (Xq21.3) and is suggested to have 
originated from the retrotransposition of autosomal 
TGIF2.TheTGIF2LX has 2 exons with a 96 base-pair 
intron. Although TGIF2 and TGIF2LXshow extensive 
variations, they share conservationally within the 
homeodomain, and the C-terminus region (12). 
An abnormal expression of TGIF2LX gene in some 
prostate tumors, but not in normal and benign prostate 
hyperplasia, has been shown (13).Moreover, a possible 
associationofTGIF2LX/Y mRNA expression with human 
azoospermia has been reported in the Iranian patients 
affected by infertility (14). Another study showed that 
TGIF2LX gene is differentially expressed in 
glioblastoma and astrocytoma cell lines suggesting a 
potential function of this gene in brain tumorigenesis 
(15). 
The present study aimed at identifying potential 
humanTGIF2LX target gene(s) using cDNA-AFLP as a 
differential display method.  
 
Materials and Methods 
 
Cell culture 
The colon adenocarcinoma cell line, SW48, was 
grown in RPMI-1640 medium (Gibco, Germany) 
containing 25 mM D-glucose, 4 mM L-glutamine and 
1 mM sodium pyruvate and supplemented with 5% 
(v/v) heat-inactivated fetal bovine serum (FBS) 
(Gibco, Germany) 2 mM glutamate (Gibco, 
Germany), 100 units/ml penicillin, 100 µg/ml 
streptomycin and 250 ng/ml amphotericin (Gibco, 
Germany) in culture flask 25 cm2 (SPL Life Sciences, 
South Korea). The cells were incubated at 37°C in a 
humidified 95% atmosphere, 5% CO2 atmosphere 
incubator designated as theculture at a steady-state 
condition (16,17). 
 
 
Cell transfection 
In our previous study, we designed and cloned the 
entire coding region of TGIF2LX into the pEGFP-
N1vector (15). We transfected subcultured SW48 cells 
using X-treme GENE siRNA Transfection Reagent 
(Roche, Applied Science, and Germany) either with 
pEGFP carrying TGIF2LX cDNA sequence or empty 
pEGFP plasmid according to the manufacturer’s 
instructions. After 24 to 48 hours, transfection was 
examined using an Olympus fluorescent inverted 
microscope. The following day, the cells were cultured 
in the presence of 800 µg/mL G418 (Life Technologies) 
for 21 days to select highly expressing GFP cells. As a 
maintenance dose, the cells were cultured in the 
presence of 200 µg/mL of G418 (Life Technologies). 
 
RNA extraction and cDNA synthesis 
Total RNA was extracted by the TriZol reagent 
(Invitrogen, USA) following the manufacturer’s 
instructions. The quality and quantity of total RNA were 
verified by gel electrophoresis and optical density 
reading with a NanoDrop (ThermoScientific2000, 
USA).Total RNA was treated with DNaseI (Invitrogen, 
USA). Then, 5 µg of total RNA was used to synthesize 
cDNA fragments using random sequence hexamer 
primers and OligodT with a cDNA synthesis system kit 
(Vivantis, USA), according to the manufacturer’s 
protocol.  
 
cDNA-AFLP 
A modified cDNA-AFLP procedure was performed 
as described previously (18-20). Double-stranded 
cDNA (dscDNA) was synthesized at 16 °C for 2 h with 
DNA polymeraseI (Thermo Scientific, USA). The 
resulting double-stranded cDNA was then digested with 
5 U EcoRI, (Fermentas, Canada) at 37 °C for 2 hand 
PCR templates were generated. Subsequently, the 
adaptors were ligated toT4-DNA ligase (Vivantis, USA) 
overnight at 16°C, and one-tenth of this reaction volume 
was used for pre-amplification with PrEcoRI primers 
(Table1) in a 50 µl reaction volume.  
The PCR condition was as following steps: initial 
denaturation at 95°C for 5 min followed by 30 
amplification cycles at 94°C for 40 s, 60°C for 40 s, and 
72°C for 1.5 min, and a final extension at 72°C for 7 min. 
The sensitive amplification was also carried out by 
sensitive primers. These primers contained adaptor 
sequences plus one variable nucleotide at the 3´ end. The 
products resulting from sensitive amplifications were 
separated on 10% non-denaturing polyacrylamide gel 
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electrophoresis (PAGE) and stained with silver nitrate 
according to the protocol (21). Finally, the gels were 
scanned and checked for the presence of differentially 
expressed transcription-derived fragments (TDFs). 
 
Isolation, cloning, and sequence analysis of 
transcript-derived fragments 
Based on their intensity of up-regulation and down-
regulation, the bands that were obviously changed were 
selected and cut from the gels with a surgical blade. The 
gel was dissolved in 100 µl sterile water with vigorous 
vortexing for 1 min, and incubated in boiling water for 
30 min. A 5 µl portion of each dissolved band was re-
amplified using appropriate, sensitive adaptors. After 
checking PCR products on 1.5% agarose gel, they were 
cloned into a pTZ57R/T Vector (Thermo scientific, 
USA). There combinant plasmid containing the TDF of 
interest was subjected to sequencing using universal 
primers (M13 (-20) forward and reverse primer) 
(Fermentase,USA); this was done to identify the isolated 
TDFs. Sequence data were analyzed in a non-redundant 
nucleic and protein databases, namely BLAST (Basic 
Local Alignment Search Tool) 
(http://www.ncbi.nim.nih.gov/BLAST). 
 
Real-time RT-PCR analysis 
Real-time RT-PCR was conducted to confirm the 
differences in expression patterns of TDF-derived genes, 
For expression analysis, specific primers were designed 
using the NCBI primer–BLAST program 
(http://www.ncbi.nih.gov/primer-BLAST). A 
quantitative Real-time PCR was performed in a total 
volume of 20 µl that contained 2 µl cDNA, 10 µl of 
SYBR Green I Taq Mix (Takara, Dalian, China), 1 µl 
(0.2 mM) of each primer, and 6 µl ddH2O. Experiments 
were performed in triplicate using a CFX96™ Real-
Time System (C1000TM Thermal Cycler) (Bio-Rad, 
Hercules, CA, USA). The PCR condition followed this 
steps: initial denaturationat 95°C for 3 min followed 
by45 amplification cycles containing denaturation at 
95°C for 10 s, annealing at 60°C for 32 s and extension 
at 72° for 1.5 min, and a final extension at 72°C for 7 
min. The amplification products were heated to 95°C to 
determine their melting curves and confirm their 
specificity. Glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH) gene expression was used as a housekeeping 
gene to normalize data. The cycle thresholds (CTs) of 
the identified genes were compared with that of the 
house keeping gene (GAPDH),the relative expression 
level of each target gene was analyzed by using the 2 -
∆∆CT method (22,23). 
 
Results 
 
The entire coding region of TGIF2LX was cloned 
into the pEGFP-N1 vector. The TGIF2LX expression 
was detected by RT-PCR. Plasmids containing the 
correct sequence were transfected into SW48 cell line, 
and the TGIF2LX-GFP fusion protein is expressed. The 
fluorescent microscopic study revealed that the 
TGIF2LX-GFPwasmainly localized to nuclei (Figure 1). 
 
 
Figure 1. TGIF2LX gene expression detected by fluorescent microscopy. SW48 cells 21 days after post-transfection with a light microscope (A). 
SW48 cells transfected with empty plasmid pEGFP (B), and with plasmid pEGFP- TGIF2LX (C) under a fluorescent microscope (×20). 
 
 
cDNA-AFLP analyses were carried out on SW48 
with either pEGFP plasmid with TGIF2LX cDNA 
sequence or pEGFP plasmid without TGIF2LX cDNA 
sequence; this was done to investigate target gene(s) of 
the TGIF2LXThe cDNA AFLP products from different 
primer combinations were resolved on 10% non-
denaturing PAGE (Figure 2) different bands containing 
TDFs were extracted from PAGEs, amplified and 
subcloned into T-vector for sequencing so that it was 
possible to detect TGIF2LX target genes. The sequence 
obtained for each TDF was compared with the Gen 
Bank non-redundant public sequence database BLAST 
program (24). 
In this study, different mRNA expression levels 
ofNir1 and Nir2genes, and two other unknown genes 
were detected in SW48 cells containing plasmid pEGFP-
TGIF2LX compared to cells containing the empty 
pEGFP plasmid. 
 
Validation of cDNA AFLP results using real time PCR  
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After identification by cDNA-AFLP, gene 
expression was further investigated in order to identify 
two TDFs using qRT-PCR by specific primers (Table 1). 
These TDFs were selected based on the expression 
intensity and differential patterns of expression in the 
cDNA-AFLP experiment. According to the qRT-PCR 
results, Nir1 and Nir2 were found to be down-regulated 
and up-regulated, respectively(Figure 3). 
 
 
Figure 2. The pattern of TDFs extracted from cDNA-AFLP PAGE. Sensitive amplification of cDNA-AFLP on a PAGE from different primer 
combinations: S1 EcoRI /S2 EcoRI, S1 EcoRI /S3 EcoRI, and S2 EcoRI /S3 EcoRI, and S3 EcoRI /S4 EcoRI, and S4 EcoRI /S4 EcoRI. The arrows 
indicate extracted TDFs. N: SW48 cells transfected with empty plasmid pEGFP, X: SW48 cells transfected with pEGFP- TGIF2LX. 
 
 
Figure 3.Relative expression pattern of Nir1 and Nir2 genes by real time RT-PCR. Nir2 gene showed increased expression level, and Nir1 gene 
showed decreased expression level after normalization with internal control (GAPDH)(P<0.001). 
 
 
Table 1. Sequences of adaptors and primer used in this study 
Primer name  Sequences PCR product size (bp) 
Primer 
name 
Housekeeping 
 
GAPDH-F 5’-CACCAGGGCTGCTTTTAAC-3’ 
190 bp 
GAPDH-R 5’-ATCTCGCCTCCTGGAAGAT-3’ 
cDNA AFLP 
Adaptorsand 
Primers 
AdL Ecor 1 5’-ACCGACGTCGACTATCCATGAAG -3’ -- 
AdS EcoR 1 5’- AATTCTTCATGG -3’ -- 
Pr EcoR 1 5’- ACCGACGTCGACTATCCATGAAGAATTC -3’ -- 
S1 EcoR 1 5’- ACCGACGTCGACTATCCATGAAGAATTCC -3’ -- 
S2 EcoR 1 5’- ACCGACGTCGACTATCCATGAAGAATTCG -3’ -- 
S3 EcoR 1 5’- ACCGACGTCGACTATCCATGAAGAATTCA -3’ -- 
S4 EcoR1 5’- ACCGACGTCGACTATCCATGAAGAATTCT -3’ -- 
Target Gene 
Nir 1 – F 5’- TATCGGATCGCCAAGTTGCT-3’ 
169 bp 
Nir 1 – R 5’-TTGCAGAATCACCCCAAAGC-3’ 
Nir 2 – F 5’- GTAGAACTGAACATCGTGGCCG-3’ 
151 bp 
Nir 2 – R 5’- CCACATAGCCGTCTGACAGGA-3’ 
 
Discussion 
 
Colorectal cancer is one of the common 
malignancies worldwide, with one million new cases 
each year. Determination of new target genes as 
molecular markers is useful for the cancer prognosis and 
helps to select therapeutic strategies (25,26). 
The present study was conducted to identify 
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downstream genes regulated by TGIF2LX. It is possible 
that TGIF2LX, like the majority of homeobox genes, 
activates or represses downstream target gene(s) via 
direct or indirect manners. It was found in the present 
study that Nir1 (also known as PITPNM3) and Nir2 act 
as twoTGIF2LX target genes. It was also revealed that 
Nir1was down-regulated while Nir2 wasup-regulated. 
The Nir family members have been favorably 
conserved during evolution. PITPNM3 contains 20 
exons spanning approximately 101 kb of genomic 
sequence and encodes a protein belonging to 
phosphatidyl-inositol transfer protein (PITP) family. Nir 
proteins show tissue-specific expression pattern. The 
Nir1gene is expressed in the human retina, brain, spleen, 
ovary and breast cancer cells (27-29). Whereas Nir2 is 
expressed in various tissues and cell types, including 
neuronal, epithelial, and hematopoietic cells (30). 
Evidence suggests that Nir2 is an important regulator of 
cell morphogenesis and its ectopic expression 
remarkably affects cell morphology (31). It has been 
revealed that Nir2is essential for cytokinesis; blocking 
of Nir2 function by PITPNM1 antibody injection results 
in the production of multinucleated cell formation. 
Overall, any changes in Nir2 structure lead to an 
abnormalcytokinesis (32). 
It has been demonstrated that Nir1 is a functional 
receptor for CCL18 (a Tumor-associated macrophages-
derived cytokine). Expression and functional role of 
PITPNM3 in breast cancer cells support the correlation 
of CCL18-expressing TAM count with prognosis due to 
increased CCL18 production that may have a stronger 
metastasis-promoting effect on breast cancer cells. 
CCL18 promotes breast cancer invasion, metastasis, and 
reduces patient survival; whereas PITPNM3 suppression 
would reverse these effects (33). In contrary, PITPNM3 
is scarcely detected in gastric cancer cells (34). 
It has been documented that Nir1 and Nir2 have 
different expression patterns in retinal cells. Their 
characteristic and expression pattern may indicate 
several roles in cellular processes. While Nir1 is 
predominantly expressed in premature cells, Nir2 is 
homogeneously distributed in undifferentiated 
neuroblasts and ganglion cells at birth but later becomes 
distinctly distributed in newly differentiated neuronal 
cells (35). The results obtained in the present study are 
in agreement with the results of the above-mentioned 
study except that in the present study Nir2 as a 
TGIF2LX target was up-regulated in colorectal 
adenocarcinoma grade 4 which resulted in the increased 
in tissue differentiation and decrease in cancerogenesis. 
On the other hand, lack of TGIF2LX expression leads to 
carcinogenesis. Therefore, it seems that TGIF2LX acts 
as tumor suppressor gene, but Nir1 is a proto-oncogene. 
Overall, the present study identified two target genes 
of TGIF2LX, which would be involved in the cell 
morphogenesis processes. These findings may provide 
new insight into the complex molecular pathways 
underlying colorectal cancer development. 
 
References 
 
1. Imoto I, Pimkhaokham A, Watanabe T, et al. 
Amplification and overexpression of TGIF2, a novel 
homeobox gene of the TALE superclass, in ovarian cancer 
cell lines. Biochem Biophys Res Commun 
2000;276(1):264-70. 
2. Hu Y, Yu H, Shaw G, et al. Differential roles of TGIF 
family genes in mammalian reproduction. BMC Dev Biol 
2011;11:58.  
3. Holland PW, Booth HA, Bruford EA. Classification and 
nomenclature of all human homeobox genes. BMC Biol 
2007;5:47.  
4. Reza Raoofian, Mohammad Reza Noori-Daloii, Samira 
Saee-Rad, et al. Differential expression of human 
homeodomain TGIFLX in brain tumor cell lines. Acta 
Med Iran 2013;51(12):834-41. 
5. Bertolino E, Reimund B, Wildt-Perinic D, et al. A novel 
homeobox protein which recognizes a TGT core and 
functionally interferes with a retinoid-responsive motif. J 
Bioll Chem 1995;270(52):31178-88. 
6. Melhuish TA, Gallo CM, Wotton D. TGIF2 interacts with 
histone deacetylase 1 and represses transcription. J Biol 
Chem 2001;276(34):32109-14.  
7. Powers SE, Taniguchi K, Yen W, et al. Tgif1 and Tgif2 
regulate Nodal signaling and are required for gastrulation. 
Development 2010;137(2):249-59. 
8. Burglin TR. Analysis of TALE superclass homeobox 
genes (MEIS, PBC, KNOX, Iroquois, TGIF) reveals a 
novel domain conserved between plants and animals. 
Nucleic Acids Res 1997;25(21):4173-80. 
9. Hyman CA, Bartholin L, Newfeld SJ, et al. Drosophila 
TGIF proteins are transcriptional activators. Mol Cell Biol 
2003;23(24):9262-74. 
10. Wang Y, Wang L, Wang Z. Transgenic analyzes of TGIF 
family proteins in Drosophila imply their role in cell 
growth. JGenet Genomics2008;35(8):457-65.  
11. Yu YY, Pan YS, Zhu ZG. Homeobox genes and their 
functions on development and neoplasm in gastrointestinal 
tract. Eur JSurg Oncol 2007;33(2):129-32. 
12. Blanco-Arias P, Sargent CA, Affara NA. The human-
specific Yp11.2/Xq21.3 homology block encodes a 
potentially functional testis-specific TGIF-like retroposon. 
Gh.R. Mobini, et al. 
        Acta Medica Iranica, Vol. 54, No. 5 (2016)    307 
Mamm Genome 2002;13(8):463-8.  
13. Ousati Ashtiani Z, Ayati M, Modarresi MH, et al. 
Association of TGIFLX/Y mRNA expression with prostate 
cancer. Med Oncol 2009;26(1):73-7.  
14. Aarabi M, Ousati-Ashtiani Z, Nazarian A, et al. 
Association of TGIFLX/Y mRNA expression with 
azoospermia in infertile men. Mol Reprod Dev 
2008;75(12):1761-6.  
15. Raoofian R, Noori-Daloii MR, Saee-Rad S, et al. 
Differential expression of human homeodomain TGIFLX 
in brain tumor cell lines. Acta Med Iran 2013;51(12):834-
41. 
16. Akbari A, Amanpour S, Muhammadnejad S, et al. 
Evaluation of antitumor activity of a TGF-beta receptor I 
inhibitor (SD-208) on human colon adenocarcinoma. Daru 
2014;22:47 
17. Akbari A, Ghahremani MH, Mobini GR, et al. Down-
regulation of miR-135b in colon adenocarcinoma induced 
by a TGF-β receptor I kinase inhibitor (SD-208). Iran J 
Basic Med Sci 2015;18(9):856-61. 
18. Saffari M, Dinehkabodi OS, Ghaffari SH, et al. 
Identification of novel p53 target genes by cDNA AFLP in 
glioblastoma cells. Cancer Lett 2009;273(2):316-22. 
19. Elham Kazemi-Rad MM, Mohammad Bagher Khadem-
Erfan, Mojtaba Saffari,et al. Identification of antimony 
resistance markers in Leishmania tropica field isolates 
through a cDNA-AFLP approach. Exp Parasitol 
2013;135(2):344-9. 
20. Bagher Khadem Erfan M, Mohebali M2, Kazemi-Rad E, et 
al. Downregulation of Calcineurin Gene Is Associated with 
Glucantime Resiatance in Leishmania infantum. Iran J 
Parasitol 2013;8(3):359-66. 
21. Bassam BJ, Caetano-Anolles G, Gresshoff PM. Fast and 
sensitive silver staining of DNA in polyacrylamide gels. 
Anal Biochem 1991;196(1):80-3.  
22. Livak KJ, Schmittgen TD. Analysis of relative gene 
expression data using real-time quantitative PCR and the 
2(-Delta Delta C(T)) Method. Methods 2001;25(4):402-8. 
23. Akbari A, Mobini GR, Maghsoudi R, et al. Modulation of 
transforming growth factor-β signaling transducers in 
colon adenocarcinoma cells induced by staphylococcal 
enterotoxin B. Mol Med Rep 2016;13(1):909-91. 
24. Altschul SF, Madden TL, Schaffer AA, et al. Gapped 
BLAST and PSI-BLAST: a new generation of protein 
database search programs. Nuclic Acids Res 
1997;25(17):3389-402.  
25. Shen A, Chen H, Chen Y, et al. Pien Tze Huang 
Overcomes Multidrug Resistance and Epithelial-
Mesenchymal Transition in Human Colorectal Carcinoma 
Cells via Suppression of TGF-beta Pathway. Evid Based 
Complement Alternat Med2014;2014:679436. 
26. Yang J, Fu M, Ding Y, et al. High SHIP2 Expression 
Indicates Poor Survival in Colorectal Cancer. Dis Markers 
2014;2014:218968.  
27. Krohn S, Garin A, Gabay C, et al. The Activity of CCL18 
is Principally Mediated through Interaction with 
Glycosaminoglycans. Front Immunol 2013;4:193. 
28. Lev S. Molecular aspects of retinal degenerative diseases. 
Cell Mol Neurobiol 2001;21(6):575-89.  
29. Ocaka L, Spalluto C, Wilson DI, et al. Chromosomal 
localization, genomic organization and evolution of the 
genes encoding human phosphatidylinositol transfer 
protein membrane-associated (PITPNM) 1, 2 and 3. 
Cytogenet Genome Res 2005;108(4):293-302. 
30. Lev S, Hernandez J, Martinez R, et al. Identification of a 
novel family of targets of PYK2 related to Drosophila 
retinal degeneration B (rdgB) protein. Mol Cell Biol 
1999;19(3):2278-88.  
31. Tian D, Litvak V, Toledo-Rodriguez M, et al. Nir2, a 
novel regulator of cell morphogenesis. Mol Cell Biol 
2002;22(8):2650-62. 
32. Litvak V, Tian D, Carmon S, et al. Nir2, a human homolog 
of Drosophila melanogaster retinal degeneration B protein, 
is essential for cytokinesis. Mol Cell Biol 
2002;22(14):5064-75.  
33. Chen J, Yao Y, Gong C, et al. CCL18 from tumor-
associated macrophages promotes breast cancer metastasis 
via PITPNM3. Cancer Cell 2011;19(4):541-55. 
34. Leung SY, Yuen ST, Chu KM, et al. Expression profiling 
identifies chemokine (C-C motif) ligand 18 as an 
independent prognostic indicator in gastric cancer. 
Gastroenterology2004;127(2):457-69. 
35. Tian D, Lev S. Cellular and developmental distribution of 
human homologues of the Drosophilia rdgB protein in the 
rat retina. Invest Ophthalmol Vis Sci 2002;43(6):1946-53. 
 
